| 摘要 |
<p>The present invention relates to compounds of Formula (1) wherein R1 R4, A, D, and L are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases.</p> |
